Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of the DNA-testing company she co-founded.

Anne Wojcicki, founder of 23andMe, has successfully repurchased the genetic testing firm out of bankruptcy through her ...

Anne Wojcicki has asked the judge in bankruptcy proceedings for 23andMe, the genetic testing company she founded and led until earlier this year, to allow additional bids for the business.

In 2008, Anne Wojcicki ... control and board oversight”, she wrote this week. From the outset, Wojcicki had bolder visions than ancestry exploration. She was eager to leverage 23andMe’s ...

23andMe Holding Co. co-founder and Chief Executive Officer Anne Wojcicki told employees that she remains committed to taking the genetic testing company private following the resignation of its ...

Wojcicki, who controls nearly 50% of the company's voting shares, submitted a proposal in August to pay out 40 cents per share to shareholders in return for total control of 23andMe. The board ...

After outlining plans nearly one year ago to take 23andMe private ... future is unwavering,” Wojcicki wrote. “Consumers are rising up and asking for more control over their health and ...

The bidding competition over 23andMe may not be over. The founder of 23andMe, Anne Wojcicki, has asked a federal bankruptcy court judge to reopen an auction for the genetic testing company ...

Wojcicki's newly established nonprofit TTAM Research Institute has offered $305 million for 23andMe, which will now serve as the starting price for a fresh process, The Wall Street Journal reported.